Category Archives: Focus on patients

Pradaxa: Case study on DTC marketing moratorium ?

In the first quarter of 2011, the FDA received 40,151 domestic reports of serious, disabling or fatal injury associated with drug therapy. The total represented a 3% increase over the previous calendar quarter, and a 19.5% increase over the first quarter of 2010.   Continue reading

Not another study on a medication that I take !?

How much worse can it get for consumers and their healthcare ?  Now a report says that statins increase the risk of developing diabetes in postmenopausal women, according to a new study published in Archives of Internal Medicine. The study provides more evidence and details about the previously reported link between statins and the development of diabetes.  More confusion for patients to work through. Continue reading

Drug shortages turn ADHD drugs into valuable product

Not too long ago there were a lot of people who said that ADHD drugs were overprescribed. They feel that there are a variety of reasons [ADHD drugs are overprescribed]: Parents are desperate for a fix, drug companies have done an incredible job marketing the drugs as a panacea, and culture has pathologized boyhood, making more people believe something is wrong with their son. But now, with a shortage of these drugs, people are asking “where can I purchase these drugs ?” Continue reading

Some medication safety tips

According to the Centers for Disease Control and Prevention, unintentional prescription drug overdoses have risen steadily since the 1970’s. This statistic magnifies the importance of proper medication use education. Continue reading

Content is king but does the drug industry understand that ?

When was the last time you though of a pharma brand as an expert or authority on a health condition ?  Chances are it’s been a long time.  One brand, Lipitor, comes to mind when I think of cholesterol but other brands have not made that emotional content connection to be thought of as an authority on health conditions they treat. Continue reading

The conversion path to an Rx is rarely a straight line

With less people going to see their doctor and with non-compliance and adherence at record high levels the path to conversion for Rx drugs has become a journey from one point to another.  Pharma marketers have to ensure that their marketing mix is optimized for each channel so that DTC marketing can have maximum impact and ROI. Continue reading

DTC marketing: Part II on why TV is king of spending

There were a lot of great comments around yesterdays post on how pharma continues to waste money on TV.  Thank you all for you comments and eMails.   I really believe that the continued investment in TV is indicative of core problem within pharma marketing and that is that marketers continue to believe that push marketing works for Rx drugs.  Today that just isn’t true. Continue reading

2012: The year of DIY health ?

Technology meets healthcare.  Is 2012 going to be year for DIY health ?   There are number of apps and medical devices headed to the market which is going to allow people to monitor their health at home and send results to a HCP.  With less people going to see their doctor and a lot of people going online for health information one has to wonder where DIY healthcare is headed ? Continue reading

Alzheimer’s Disease and Boomers fears

Americans are equally afraid of caring for a loved one with Alzheimer’s disease as they are of getting Alzheimer’s disease themselves.  Approximately one in two American adults (49%) are as afraid of taking care of a loved one with Alzheimer’s disease as they are of getting the disease themselves.  Boomers biggest fear when growing old?  Loosing their ability to think, reason and remember.   Continue reading

Physician visits by privately insured patients decline 17%:Recommendations for DTC Marketers

Physician office visits by privately insured patients younger than 65 have fallen 17% in two years, according to a Kaiser Family Foundation analysis released Nov. 15.    The quarterly number of office visits by privately insured patients had reached 160 million by 2005 then was at a plateau until the recession hit, according to an analysis prepared for Kaiser at Stanford University using data collected by IMS Health. Continue reading

Healthcare is changing but DTC marketing still stuck in the past

Healthcare in America is changing. Hospitals are scrambling to buy hospitals. Doctors are leaving small private practices. Large insurance companies are becoming more dominant as smaller ones disappear because they cannot stay competitive. States are simplifying decades of Medicaid rules and planning new ways for poor and rich alike to buy policies more easily and less patients are going to see their doctor, spending more time online researching health and getting more involved in wellness.  Where are most DTC marketers ?  On the sideline watching it all happen. Continue reading